ConductScience.org, home

Paper540362

A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii.

Hirai Y and 5 others. Chem Pharm Bull (Tokyo), 1979. Cited by 251 papers, by iCite.

Cite this record

ConductScience Library. A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii. Papers, record 540362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/540362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii.
PubMed
Journal
Chem Pharm Bull (Tokyo)
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
251
iCite
Relative citation ratio, by iCite
6.56
iCite
Revised in PubMed
2019-07-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hirai YY
2Yasuhara TT
3Yoshida HH
4Nakajima TT
5Fujino MM
6Kitada CC

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bee VenomsMajor topic
Mast CellsMajor topic
PeptidesMajor topic
Wasp VenomsMajor topic
Amino Acid Sequence
Animals
Rats

Source PubMed

Download CSV of topics

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 251 citations.

PMIDTitleJournalYearIn PapersSource
42028705Antimelanoma Activity of the Mastoparan Peptides MPX and MP1: Cellular Selectivity and Mechanism of Action.Mol Pharm2026https://conductscience.org/library/papers/42028705PubMed
41117102Prolonged IL-33 Exposure Switches the Secreted Mast Cell Cytokine Profile From Pro-Inflammatory to Pro-Tolerant.Allergy2026https://conductscience.org/library/papers/41117102PubMed
40316781Invertebrate venoms: A treasure trove of bioactive compounds with anticancer potential.Arch Toxicol2025https://conductscience.org/library/papers/40316781PubMed
39914508Mast cell activators as adjuvants for intranasal mucosal vaccines.Int J Pharm2025https://conductscience.org/library/papers/39914508PubMed
39828882New Frontiers in Fighting Mycobacterial Infections: Venom-Derived Peptides.Probiotics Antimicrob Proteins2025https://conductscience.org/library/papers/39828882PubMed
38629875Employment of mastoparan-like peptides to prevent Staphylococcus aureus associated with bovine mastitis.J Bacteriol2024https://conductscience.org/library/papers/38629875PubMed
37833918A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity.Int J Mol Sci2023https://conductscience.org/library/papers/37833918PubMed
37317314Mutualistic Relationships between Microorganisms and Eusocial Wasps (Hymenoptera, Vespidae).Microorganisms2023https://conductscience.org/library/papers/37317314PubMed
37235365Characterization of the Molecular Diversity and Degranulation Activity of Mastoparan Family Peptides from Wasp Venoms.Toxins (Basel)2023https://conductscience.org/library/papers/37235365PubMed
36837754
Antimicrobial Peptide Mastoparan-AF Kills Multi-Antibiotic Resistant Escherichia coli O157:H7 via Multiple Membrane Disruption Patterns and Likely by Adopting 3-11 Amphipathic Helices to Favor Membrane Interaction.
Membranes (Basel)2023https://conductscience.org/library/papers/36837754PubMed
35813822Mastoparans: A Group of Multifunctional α-Helical Peptides With Promising Therapeutic Properties.Front Mol Biosci2022https://conductscience.org/library/papers/35813822PubMed
35547769Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer.Theranostics2022https://conductscience.org/library/papers/35547769PubMed
35454116Bioactive Peptides and Proteins from Wasp Venoms.Biomolecules2022https://conductscience.org/library/papers/35454116PubMed
34693965Spiers Memorial Lecture: Analysis and de novo design of membrane-interactive peptides.Faraday Discuss2021https://conductscience.org/library/papers/34693965PubMed
34621137Therapeutic Potential of Peptides Derived from Animal Venoms: Current Views and Emerging Drugs for Diabetes.Clin Med Insights Endocrinol Diabetes2021https://conductscience.org/library/papers/34621137PubMed
34249119Effects of venoms on neutrophil respiratory burst: a major inflammatory function.J Venom Anim Toxins Incl Trop Dis2021https://conductscience.org/library/papers/34249119PubMed
33951631Bee- and Wasp-Venom Sensitization in Schoolchildren of High- and Low-Socioeconomic Status Living in an Urban Area of Indonesia.Int Arch Allergy Immunol2021https://conductscience.org/library/papers/33951631PubMed
33671927Cell-Penetrating Peptides Derived from Animal Venoms and Toxins.Toxins (Basel)2021https://conductscience.org/library/papers/33671927PubMed
32038544Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates?Front Microbiol2019https://conductscience.org/library/papers/32038544PubMed
31557900Natural Occurrence in Venomous Arthropods of Antimicrobial Peptides Active against Protozoan Parasites.Toxins (Basel)2019https://conductscience.org/library/papers/31557900PubMed

See all 60 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/540362

GET https://conductscience.org/api/papers/v1/540362/cited_by?page=2